End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.16 USD | -3.76% | -5.29% | -15.27% |
Financials (USD)
Sales 2024 * | 28.88M | Sales 2025 * | 43.41M | Capitalization | 194M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -44M | EV / Sales 2024 * | 6.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.48 x |
P/E ratio 2024 * |
-4.01
x | P/E ratio 2025 * |
-5.49
x | Employees | 112 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.41% |
Latest transcript on TriSalus Life Sciences, Inc.
1 day | -3.76% | ||
1 week | -5.29% | ||
1 month | -23.09% | ||
3 months | -23.18% | ||
6 months | +97.79% | ||
Current year | -15.27% |
Managers | Title | Age | Since |
---|---|---|---|
Mary Szela
CEO | Chief Executive Officer | 60 | 17-12-31 |
Sean Murphy
DFI | Director of Finance/CFO | 71 | 23-08-09 |
Steven Katz
CTO | Chief Tech/Sci/R&D Officer | 49 | 23-08-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kerry Hicks
BRD | Director/Board Member | 64 | 23-08-09 |
Mats Wahlström
CHM | Chairman | 70 | 23-08-09 |
George Martin
BRD | Director/Board Member | 65 | 23-08-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 7.16 | -3.76% | 31,998 |
24-05-30 | 7.44 | -0.80% | 63,644 |
24-05-29 | 7.5 | -5.06% | 29,102 |
24-05-28 | 7.9 | +4.50% | 105,591 |
24-05-24 | 7.56 | -20.75% | 353,134 |
End-of-day quote Nasdaq, May 30, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.27% | 194M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- TLSI Stock